Stress and Western diets increase vulnerability to neuropsychiatric disorders: A common mechanism

References

• Simopoulos AP. Evolutionary aspects of the dietary Omega-6:Omega-3 fatty acid ratio: Medical implications. World Rev Nutr Diet. 2009;100:1–21.
   PubMedGoogle Scholar
• Tafet GE, Bernardini R. Psychoneuroendocrinological links between chronic stress and depression. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(6):893–903.
   PubMed Web of Science ®Google Scholar
• Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319.
   PubMed Web of Science ®Google Scholar
• Li Y, Lv MR, Wei YJ, Sun L, Zhang JX, Zhang HG, et al. Dietary patterns and depression risk: a meta-analysis. Psychiatry Res. 2017;253:373–82.
   PubMed Web of Science ®Google Scholar
• Selye H. A Syndrome produced by diverse nocuous agents. Nature. 1936;138:32.
   Web of Science ®Google Scholar
• Selye H. The stress of life. NY: McGraw-Hill Education; 1956.
   Google Scholar
• Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24:151–80.
   PubMed Web of Science ®Google Scholar
• Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry. 1999;4:163–72.
   PubMed Web of Science ®Google Scholar
• Tafet GE, Nemeroff CB. The Links between stress and depression: Psychoneuroendocrinological, Genetic, and environmental interactions. J Neuropsych Clin Neurosci. 2016;28:77–88.
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci. 2006;8:367–81.
   PubMedGoogle Scholar
• Lemos JC, Wanat MJ, Smith JS, Reyes BA, Hollon NG, Van Bockstaele EJ, et al. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature. 2012;490:402–6.
   PubMed Web of Science ®Google Scholar
• Henckens MJAG, Deussing JM, Chen A. Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. Nat Rev Neurosci. 2016;17:636–51.
   PubMed Web of Science ®Google Scholar
• Slater PG, Cerda CA, Pereira LA, Andrés ME, Gysling K. CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface. Proc Natl Acad Sci. 2016;17:636–51.
   Google Scholar
• Hennebelle M, Champeil-Potokar G, Lavialle M, Vancassel S, Denis I. Omega-3 polyunsaturated fatty acids and chronic stress-induced modulations of glutamatergic neurotransmission in the hippocampus. Nutr Rev. 2014;72:99–112.
   PubMed Web of Science ®Google Scholar
• McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Pros Leuk Esse Fatty Acids. 2006;75:329–49.
   PubMed Web of Science ®Google Scholar
• Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-Mediated control of synaptic transmission. Physiol Rev. 2009;89:309–80.
   PubMed Web of Science ®Google Scholar
• Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 2004;145:5431–8.
   PubMed Web of Science ®Google Scholar
• Gorzalka BB, Hill MN, Hillard CJ. Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders. Neurosci Biobehav Rev. 2008;32:1152–60.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Doshi M, Hamazaki T. n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids. 2003;69:51–9.
   PubMed Web of Science ®Google Scholar
• Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ, Makriyannis A. Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res. 2010;51:1416–23.
   PubMed Web of Science ®Google Scholar
• Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta. 2008;1781:200–12.
   PubMed Web of Science ®Google Scholar
• Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci. 2011;14(3):345–50.
   PubMed Web of Science ®Google Scholar
• Larrieu T, Madore C, Joffre C, Layé S. Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. J Physiol Biochem. 2012;68:671–81.
   PubMed Web of Science ®Google Scholar
• Larrieu T, Hilal ML, Fourrier C, Desmedt-Peyrusse V, Sans N, Capuron L, et al. Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl Psychiatry. 2014;4:e437.
   PubMed Web of Science ®Google Scholar
• Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-Adrenocortical stress response. Compr Physiol. 2016;6(2):603–21.
   PubMed Web of Science ®Google Scholar
• Yonelinas AP, Ranganath C, Ekstrom AD, Wiltgen BJ. A contextual binding theory of episodic memory: systems consolidation reconsidered. Nat Rev Neurosci. 2019;26(6):364–375.
   Google Scholar
• Knierim JJ. The hippocampus. Curr Biol. 2015;25(23):R1116–21.
   PubMed Web of Science ®Google Scholar
• Witter MP, Kleven H, Kobro Flatmoen A. Comparative Contemplations on the hippocampus. Brain Behav Evol. 2017;90(1):15–24.
   PubMed Web of Science ®Google Scholar
• Younts TJ, Castillo PE. Endogenous cannabinoid signaling at inhibitory interneurons. Curr Opin Neurobiol. 2014;26:42–50.
   PubMed Web of Science ®Google Scholar
• Whissell PD, Eng D, Lecker I, Martin LJ, Wang D-S, Orser BA. Acutely increasing δGABAA receptor activity impairs memory and inhibits synaptic plasticity in the hippocampus. Front Neural Circuits. 2013;7:146.
   PubMed Web of Science ®Google Scholar
• Leão AHFF, Medeiros AM, Apolinário GKS, Cabral A, Ribeiro AM, Barbosa FF, et al. Hippocampal-dependent memory in the plus-maze discriminative avoidance task: The role of spatial cues and CA1 activity. Behav Brain Res. 2016;304:24–33.
   PubMed Web of Science ®Google Scholar
• Bast T, Pezze M, McGarrity S. Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition. Br J Pharmacol. 2017;174:3211–25.
   PubMed Web of Science ®Google Scholar
• Herman JP, Dolgas CM, Carlson SL. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors. Neuroscience. 1998;86:449–59.
   PubMed Web of Science ®Google Scholar
• Belleau EL, Treadway MT, Pizzagalli DA. The Impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiatry. 2018;S0006-3223:31930–9.
   Google Scholar
• Trofimiuk E, Braszko JJ. Concomitant docosahexaenoic acid administration ameliorates stress-induced cognitive impairment in rats. Physiol Behav. 2013;118:171–7.
   PubMed Web of Science ®Google Scholar
• Pérez MA, Terreros G, Dagnino-Subiabre A. Long-term ω-3 fatty acid supplementation induces anti-stress effects and improves learning in rats. Behav Brain Funct. 2013;9:25.
   PubMed Web of Science ®Google Scholar
• Pérez MÁ, Peñaloza-Sancho V, Ahumada J, Fuenzalida M, Dagnino-Subiabre A. n-3 polyunsaturated fatty acid supplementation restored impaired memory and GABAergic synaptic efficacy in the hippocampus of stressed rats. Nutr Neurosci. 2018;2:556–69.
   Google Scholar
• Thesing CS, Bot M, Milaneschi Y, Giltay EJ, Penninx BWJH. Omega-3 polyunsaturated fatty acid levels and dysregulations in biological stress systems. Psychoneuroendocrinology. 2018;97:206–15. doi:10.1016/j.psyneuen.2018.07.002.
   PubMed Web of Science ®Google Scholar
• Saunders EF, Ramsden CE, Sherazy MS, Gelenberg AJ, Davis JM, Rapoport SI. Omega-3 and Omega-6 polyunsaturated fatty acids in Bipolar disorder: A review of biomarker and treatment studies. J Clin Psychiatry. 2016;77(10):e1301–8. doi:10.4088/JCP.15r09925.
   PubMed Web of Science ®Google Scholar
• Horikawa C, Otsuka R, Kato Y, Nishita Y, Tange C, Kakutani S, et al. Cross-sectional association between serum concentrations of n-3 long-chain PUFA and depressive symptoms: results in Japanese community dwellers. Br J Nutr. 2016;115(4):672–80. doi:10.1017/S0007114515004754.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med. 2007;69(3):217–24.
   PubMed Web of Science ®Google Scholar
• Rizzo AM, Corsetto PA, Montorfano G, Opizzi A, Faliva M, Giacosa A, et al. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutr J. 2012;10(11):82. doi:10.1186/1475-2891-11-82.
   Google Scholar
• Larrieu T, Layé S. Food for Mood: Relevance of Nutritional Omega-3 fatty acids for depression and anxiety. Front Physiol. 2018;9:1047.
   PubMed Web of Science ®Google Scholar
• Opie RS, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly TN, Ruusunen A, et al. Dietary recommendations for the prevention of depression. Nutr Neurosci. 2017;20(3):161–71. doi:10.1179/1476830515Y.0000000043.
   PubMed Web of Science ®Google Scholar
• Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One. 2014;9(5):e96905. doi:10.1371/journal.pone.0096905.
   PubMed Web of Science ®Google Scholar
• Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, et al. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response. Psychoneuroendocrinology. 2015;59:1–13. doi:10.1016/j.psyneuen.2015.04.027.
   PubMed Web of Science ®Google Scholar
• Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O'Reilly SL, et al. Association of western and traditional diets with depression and anxiety in women. Am J Psychiatry. 2010;167:305–11.
   PubMed Web of Science ®Google Scholar
• Laugero KD, Smilowitz JT, German JB, Jarcho MR, Mendoza SP, Bales KL. Plasma omega 3 polyunsaturated fatty acid status and monounsaturated fatty acids are altered by chronic social stress and predict endocrine responses to acute stress in titi monkeys. Prostaglandins Leukot Essent Fat Acids. 2011;84(3–4):71–8.
   PubMed Web of Science ®Google Scholar
• Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Räsänen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord. 2004;82:447–52.
   PubMed Web of Science ®Google Scholar
• Müller CP, Reichel M, Mühle C, Rhein C, Gulbins E, Kornhuber J. Brain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta Mol Cell Biol Lipids. 2015;1851:1052–65.
   PubMed Web of Science ®Google Scholar
• Beydoun MA, Fanelli Kuczmarski MT, Beydoun HA, Rostant OS, Evans MK, Zonderman AB. Associations of the ratios of n-3 to n-6 dietary fatty acids with longitudinal changes in depressive symptoms among US women. Am J Epidemiol. 2015;181(9):691–705. doi:10.1093/aje/kwu334.
   PubMed Web of Science ®Google Scholar
• Sánchez-Villegas A, Delgado-Rodríguez M, Alonso A, Schlatter J, Lahortiga F, Majem LS, et al. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/university of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry. 2009;66(10):1090–8. doi:10.1001/archgenpsychiatry.2009.129.
   PubMed Web of Science ®Google Scholar
• Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15(1):23. doi:10.1186/s12916-017-0791-y.
   PubMed Web of Science ®Google Scholar
• Lassale C, Batty GD, Baghdadli A, Jacka F, Sánchez-Villegas A, Kivimäki M, et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019;24(7):965–86. doi:10.1038/s41380-018-0237-8.
   PubMed Web of Science ®Google Scholar
• Marsicano G, Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci. 1999;11:4213–25.
   PubMed Web of Science ®Google Scholar
• Harloe JP, Thorpe AJ, Lichtman AH. Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks. Learn Mem. 2008;15:806–9.
   PubMed Web of Science ®Google Scholar
• Hill MN, McEwen BS. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci. 2009;106:4579–80.
   PubMed Web of Science ®Google Scholar
• Puente N, Elezgarai I, Lafourcade M, Reguero L, Marsicano G, Georges F, et al. Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. PLoS One. 2010;5:e8869.
   PubMed Web of Science ®Google Scholar
• Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003;23:4850–7.
   PubMed Web of Science ®Google Scholar
• Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P, et al. Functional CB1 receptors Are Broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol. 2007;97:2580–9.
   PubMed Web of Science ®Google Scholar
• Yasuo S, Unfried C, Kettner M, Geisslinger G, Korf HW. Localization of an endocannabinoid system in the hypophysial pars tuberalis and pars distalis of man. Cell Tissue Res. 2010;342:273–81.
   PubMed Web of Science ®Google Scholar
• Ziegler CG, Mohn C, Lamounier-Zepter V, Rettori V, Bornstein SR, Krug AW, et al. Expression and function of endocannabinoid receptors in the human adrenal cortex. Horm Metab Res. 2010;42:88–92.
   PubMed Web of Science ®Google Scholar
• Ishac EJN, Jiang L, Lake KD, Varga K, Abood ME, Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1receptors on peripheral sympathetic nerves. Br J Pharmacol. 1996;118:2023–8.
   PubMed Web of Science ®Google Scholar
• Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 1984;5:1–24.
   PubMed Web of Science ®Google Scholar
• Hinz B, Hirschelmann R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm Res. 2000;17:1273–7.
   PubMed Web of Science ®Google Scholar
• Tasker JG, Di S, Malcher-Lopes R. Minireview: Rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology. 2006;147:5549–56.
   PubMed Web of Science ®Google Scholar
• Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress. 2011;14:398–406.
   PubMed Web of Science ®Google Scholar
• Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci. 2005;21:1057–69.
   PubMed Web of Science ®Google Scholar
• Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, et al. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci. 2010;107:9406–11.
   PubMed Web of Science ®Google Scholar
• Riebe CJ, Wotjak CT. Endocannabinoids and stress. Stress. 2011;14(4):384–97.
   PubMed Web of Science ®Google Scholar
• McLaughlin RJ, Hill MN, Gorzalka BB. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci Biobehav Rev. 2014;42:116–31.
   PubMed Web of Science ®Google Scholar
• Morena M, Patel S, Bains JS, Hill MN. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41(1):80–102.
   PubMed Web of Science ®Google Scholar
• Scarante FF, Vila-Verde C, Detoni VL, Ferreira-Junior NC, Guimarães FS, Campos AC. Cannabinoid modulation of the stressed hippocampus. Front Mol Neurosci. 2017;10:411.
   PubMed Web of Science ®Google Scholar
• Wamsteeker JI, Kuzmiski JB, Bains JS. Repeated stress Impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci. 2010;30:11188–96.
   PubMed Web of Science ®Google Scholar
• Dubreucq S, Matias I, Cardinal P, Häring M, Lutz B, Marsicano G, Chaouloff F. Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology. 2012;37(8):1885–900.
   PubMed Web of Science ®Google Scholar
• Hill MN, Hunter RG, McEwen BS. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields. Eur J Pharmacol. 2009;614(1-3):66–9.
   PubMed Web of Science ®Google Scholar
• Lee TT, Hill MN. Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB₁ receptor binding in male rats. Neuroscience. 2013;249:106–14.
   PubMed Web of Science ®Google Scholar
• Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 2005;30:508–15.
   PubMed Web of Science ®Google Scholar
• Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, et al. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem. 2008;106:2322–36.
   PubMed Web of Science ®Google Scholar
• Reich CG, Taylor ME, McCarthy MM. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 2009;203:264–9.
   PubMed Web of Science ®Google Scholar
• Patel S, Kingsley PJ, MacKie K, Marnett LJ, Winder DG. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology. 2009;34:2699–709.
   PubMed Web of Science ®Google Scholar
• Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, et al. Antidepressant-like activity of the fatty acid Amide Hydrolase Inhibitor URB597 in a Rat Model of chronic mild stress. Biol Psychiatry. 2007;62:1103–10.
   PubMed Web of Science ®Google Scholar
• Rodrigues SM, LeDoux JE, Sapolsky RM. The Influence of stress Hormones on Fear Circuitry. Annu Rev Neurosci. 2009;32:289–313.
   PubMed Web of Science ®Google Scholar
• van Houdenhove B, Luyten P. Stress, depression and fibromyalgia. Acta Neurol Belg. 2006;49:470–7.
   Google Scholar
• Kaufmann I, Schelling G, Eisner C, Richter HP, Krauseneck T, Vogeser M, et al. Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology. 2008;33:676–85.
   PubMed Web of Science ®Google Scholar
• Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology. 2009;34:1257–62.
   PubMed Web of Science ®Google Scholar
• Hill MN, Miller GE, Ho WSV, Gorzalka BB, Hillard CJ. Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report. Pharmacopsychiatry. 2008;41:48–53.
   PubMed Web of Science ®Google Scholar
• Szuster RR, Pontius EB, Campos PE. Marijuana sensitivity and panic anxiety. J Clin Psychiatry. 1988;49:427–9.
   PubMed Web of Science ®Google Scholar
• Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis use: Characteristics of users in an Australian rural area. Addiction. 1998;93:837–46.
   PubMed Web of Science ®Google Scholar
• Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370:1706–13.
   PubMed Web of Science ®Google Scholar
• de Mattos Viana B, Prais HAC, Daker MV. Melancholic features related to rimonabant. Gen Hosp Psychiatry. 2009;31:583–5.
   PubMed Web of Science ®Google Scholar
• Baran SE, Armstrong CE, Niren DC, Hanna JJ, Conrad CD. Chronic stress and sex differences on the recall of fear conditioning and extinction. Neurobiol Learn Mem. 2009;91:323–32.
   PubMed Web of Science ®Google Scholar
• Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. BBA - Rev Biomembr. 1984;779:89–137.
   PubMed Web of Science ®Google Scholar
• Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36:945–59.
   PubMed Web of Science ®Google Scholar
• Balsevich G, Petrie GN, Hill MN. Endocannabinoids: Effectors of glucocorticoid signaling. Front Neuroendocrinol. 2017;47:86–108.
   PubMed Web of Science ®Google Scholar
• Bowles NP, Hill MN, Bhagat SM, Karatsoreos IN, Hillard CJ, McEwen BS. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience. 2012;204:83–9.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, et al. Mechanisms of stress in the brain. Nat Neurosci. 2015;18:1353–63.
   PubMed Web of Science ®Google Scholar
• Pérez-Valenzuela C, Gárate-Pérez MF, Sotomayor-Zárate R, Delano PH, Dagnino-Subiabre A. Reboxetine improves Auditory Attention and increases norepinephrine levels in the Auditory cortex of chronically stressed rats. Front Neural Circuits. 2016;10:108.
   PubMed Web of Science ®Google Scholar
• Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 2010;35:1333–8.
   PubMed Web of Science ®Google Scholar
• Lépinay AL, Larrieu T, Joffre C, Acar N, Gárate I, Castanon N, et al. Perinatal high-fat diet increases hippocampal vulnerability to the adverse effects of subsequent high-fat feeding. Psychoneuroendocrinology. 2015;53:82–93.
   PubMed Web of Science ®Google Scholar
• Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15:771–85.
   PubMed Web of Science ®Google Scholar
• Marchalant Y, Brothers HM, Wenk GL. Inflammation and aging: Can endocannabinoids help? Biomed Pharmacother. 2008;62:212–7.
   PubMed Web of Science ®Google Scholar
• Sase S, Meyer K, Lubec G, Korz V. Different expression of membrane-bound and cytosolic hippocampal steroid receptor complexes during spatial training in young male rats. Eur Neuropsychopharmacol. 2014;24:1819–27.
   PubMed Web of Science ®Google Scholar
• Jiang CL, Liu L, Tasker JG. Why do we need nongenomic glucocorticoid mechanisms? Front Neuroendocrinol. 2014;35:72–5.
   PubMed Web of Science ®Google Scholar
• Malcher-Lopes R, Franco A, Tasker JG. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switch. Eur J Pharmacol. 2008;583:322–39.
   PubMed Web of Science ®Google Scholar
• Zamberletti E, Piscitelli F, De Castro V, Murru E, Gabaglio M, Colucci P, et al. Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system. J Lipid Res. 2017;58:301–16.
   PubMed Web of Science ®Google Scholar
• Husted KS, Bouzinova EV. The importance of n-6/n-3 fatty acids ratio in the major depressive disorder. Medicina (B Aires). 2016;52:139–47.
   PubMedGoogle Scholar
• Bosch-Bouju C, Layé S. Dietary Omega-6/Omega-3 and endocannabinoids: Implications for brain health and diseases. Chapter. 2017;6. doi:10.5772/62498.
   Google Scholar
• Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress. 2017;7:124–36. doi:10.1016/j.ynstr.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Tetel MJ, de Vries GJ, Melcangi RC, Panzica G, O'Mahony SM. Steroids, stress and the gut microbiome-brain axis. J Neuroendocrinol. 2018;30(2). doi:10.1111/jne.12548.
   PubMed Web of Science ®Google Scholar
• Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5. doi:10.1073/pnas.1102999108.
   PubMed Web of Science ®Google Scholar
• Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, et al. Targeting the microbiota-Gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and Reverse the Impact of chronic stress in mice. Biol Psychiatry. 2017;82(7):472–87. doi:10.1016/j.biopsych.2016.12.031.
   PubMed Web of Science ®Google Scholar
• Noble EE, Hsu TM, Kanoski SE. Gut to brain Dysbiosis: mechanisms Linking Western diet Consumption, the microbiome, and cognitive Impairment. Front Behav Neurosci. 2017;11(9). doi:10.3389/fnbeh.2017.00009.
   PubMedGoogle Scholar
• Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 fatty acids on the Gut microbiota. Int J Mol Sci. 2017;18(12): pii: E2645. doi:10.3390/ijms18122645.
   Web of Science ®Google Scholar
• Ghosh S, DeCoffe D, Brown K, Rajendiran E, Estaki M, Dai C, et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One. 2013;8(2):e55468. doi:10.1371/journal.pone.0055468.
   PubMed Web of Science ®Google Scholar
• Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2017;59:21–37. doi:10.1016/j.bbi.2016.07.145.
   PubMed Web of Science ®Google Scholar
• Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov. 2018;17(9):623–39. doi:10.1038/nrd.2018.115.
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24(1):27–53. doi:10.1007/s11011-008-9118-1.
   PubMed Web of Science ®Google Scholar
• Pusceddu MM, El Aidy S, Crispie F, O'Sullivan O, Cotter P, Stanton C, et al. N-3 polyunsaturated fatty acids (PUFAs) Reverse the Impact of Early-Life stress on the Gut microbiota. PLoS One. 2015;10(10):e0139721. doi:10.1371/journal.pone.0139721.
   PubMed Web of Science ®Google Scholar
• Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720–6. doi:10.1016/j.biopsych.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, de Kloet ER. Coping with the forced swim stressor: Current state-of-the-art. Behav Brain Res. 2017;364:1–10. doi:10.1016/j.bbr.2019.02.005.
   Web of Science ®Google Scholar
• de Kloet ER, Molendijk ML. Coping with the Forced Swim stressor: towards Understanding an adaptive mechanism. Neural Plast. 2016;6503162. doi:10.1155/2016/6503162.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, de Kloet ER. Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology. 2015;62:389–91. doi:10.1016/j.psyneuen.2015.08.028.
   PubMed Web of Science ®Google Scholar
• Park C, Brietzke E, Rosenblat JD, Musial N, Zuckerman H, Ragguett RM, et al. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? Brain Behav Immun. 2018;73:115–24. doi:10.1016/j.bbi.2018.07.006.
   PubMed Web of Science ®Google Scholar
• Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. 2019;102:13–23. doi:10.1016/j.neubiorev.2019.03.023.
   PubMed Web of Science ®Google Scholar
• Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, et al. Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for treatment-Resistant major depressive disorder: A Prospective Open-Label Trial. Clin Neuropharmacol. 2018;41(5):151–5. doi:10.1097/WNF.0000000000000299.
   PubMed Web of Science ®Google Scholar
• Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr. 2019 Apr;38(2):522–8. doi:10.1016/j.clnu.2018.04.010.
   PubMed Web of Science ®Google Scholar